Liver transplantation (LT) is hospital-resource intensive and associated with high rates of readmission. We have previously shown a reduction in 30-day readmission rates by implementing a specifically designed protocol to increase access to outpatient care. The aim of this work is to determine if the strategies that reduce 30-day readmission after LT were effective in also reducing 90-day readmission rates and costs. A protocol was developed to reduce inpatient readmissions after LT that expanded outpatient services and provided alternatives to readmission. The 90-day readmission rates and costs were compared before and after implementing strategies outlined in the protocol. Multivariable analysis was used to control for potential confounding factors. Over the study period, 304 adult primary LTs were performed on patients with a median biological Model for End-Stage Liver Disease of 22. There were 112 (37%) patients who were readmitted within 90 days of transplant. The readmission rates before and after implementation of the protocol were 53% and 26%, respectively (P < 0.001). The most common reason for readmission was elevated liver tests/rejection (24%). In multivariable analysis, the protocol remained associated with avoiding readmission (odds ratio, 0.33; 95% confidence interval, 0.20-0.55; P < 0.001). The median length of stay after transplant before and after protocol implementation was 8 days and 7 days, respectively. A greater proportion of patients were discharged to hospital lodging after protocol implementation (10% versus 19%; P = 0.03). The 90-day readmission costs were reduced by 55%, but the total 90-day costs were reduced by only 2.7% because of higher outpatient costs and index admission costs. In conclusion, 90-day readmission rates and readmission costs can be reduced by improving access to outpatient services and hospital-local lodging. Total 90-day costs were similar between the 2 groups because of higher outpatient costs after the protocol was introduced.
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The success of liver transplantation (LT) is remarkable with 1-year graft and patient survival rates at many centers exceeding 90%. (1) Yet, it remains resource intensive and is an expensive endeavor. The estimated cost of the LT index admission and the first year's expenses is $735,000. (2) Readmissions account for a substantial portion of those costs with a reported 90-day readmission rate of 46%. (3) In an analysis of 11,937 LT recipients, 90-day readmissions accounted for $43,785 of added costs compared with patients who were not readmitted. (4) Factors associated with increased costs or resource utilization include pretransplant hospitalization and functional status. (5, 6) The focus on health care has shifted from volume to providing high-quality care at reduced costs. One approach to reducing resource utilization is to prevent readmissions. We have previously shown that 30-day readmission rates after LT can be reduced by 50% by developing and implementing a protocol that included strategies designed to increase outpatient access and services. (7) However, one concern was that after implementing the protocol, readmissions were simply delayed to beyond 30 days.
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The purpose of our study was to present updated data from our prior study that now includes a larger study population, to determine if our protocol was effective in reducing 90-day readmission rates, and to update results on 30-day readmission rates. A secondary aim was to compare 90-day total costs before and after implementing the protocol.
Patients and Methods
We have previously described the development of our protocol to reduce readmissions after LT. (7) The protocol was devised by a multidisciplinary, quality assurance process improvement team consisting of hepatologists, surgeons, advanced care practitioners, social workers, transplant coordinators, transplant pharmacists, dieticians, a quality management outcomes specialist, inpatient nurses, and various medical subspecialists. The principles of the protocol were to implement strategies and processes that included the following:
1. Decrease the need to consider readmission. 2. Define readmission criteria. 3. Establish outpatient alternatives to readmission.
To be successful it was important to decrease readmissions without negatively impacting patient outcomes (patient and/or graft survival) or hospital length of stay.
We observed that the readmission rates within 30 days and 90 days after LT at our center were 40% and 56%, respectively, during the periods from 2012 to 2013, which were substantially higher than reported. (3) To address the high readmission rate, in 2012, our quality improvement and process committee developed a quality improvement dashboard to collect information on readmissions and resource utilization. (7) The process followed was a "plan-do-study-act" cycle. (8) During our monthly quality improvement and process committee meetings, we planned strategies to improve outpatient services, including consultants and the infusion center, as well as to optimize the use of observation status. During the "do" stage (described later), we collected data on reducing readmission rates 30 and 90 days after discharge from the index transplant admission. We evaluated and studied 30-and 90-day readmission rates monthly during the committee meetings.
The protocol was implemented in the third quarter of 2013. The 3 principle components and details of implemented clinical pathways or strategies of the protocol "do" stage included the following:
1. Revising criteria for inpatient readmission and optimizing use of observation status. 2. Expanding outpatient services and access to consultants. 3. Refining teaching and discharge planning (Table 1) .
Expanding outpatient services included same-day access to advanced endoscopy for endoscopic retrograde cholangiopancreatography (ERCP) and embedding transplant infectious disease in the transplant center, so the infectious disease specialists could see outpatient transplant recipients within the transplant center. Improved access for ERCP resulted in utilization of observation status for recipients with suspected biliary anastomotic strictures. Refining teaching included improved coordination of inpatient teaching by the transplant coordinator and transplant pharmacist. If the inpatient team anticipated a recipient may be discharged on a weekend day, the transplant pharmacist and transplant coordinator taught the patient on Friday. The hospitality house was offered to patients who lived more than 2 hours away, and the cost was $40 per day. Data on readmission rates were prospectively collected to determine the impact of the protocol on readmission rates.
The primary aim of the current study was to determine if the 90-day readmission rate after LT was reduced after applying the strategies outlined in the protocol (Table 1) . We also provide updated results on 30-day readmission rates. Secondary outcomes were length of stay for the index admission for LT to discharge and 90-day and 1-year patient and graft survival.
Total costs were obtained from hospital financial analytics that occurred during the first 90 days after LT, including total inpatient and outpatient costs. Total costs were provided as aggregate data.
deFinitiOns
Inpatient readmission was defined using the Centers for Medicare and Medicaid Services (CMS) definition.
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From January 1, 2012, through September 30, 2013, inpatient admission was defined as recipients who stayed longer than 24 hours. (9) Observation status as defined by CMS was applied to a recipient who stayed in the hospital less than 24 hours and was not considered an inpatient admission. From October 1, 2013, to the present, the CMS definition of inpatient admission changed to more than a 2-midnight stay. A patient staying <2 midnights is considered observation status and not an inpatient readmission. To account for the change in the definition of inpatient admission over the study period, we conducted an analysis applying the current CMS definition of inpatient admission, >2-midnight stay, over the entire study period. Recipients within 90 days of LT were not admitted to outside hospitals, and if they presented to an outside emergency room, they were transferred to our center for evaluation.
Adult primary LTs using deceased donor grafts were considered for the analysis. Whole liver and split LTs were included, as were transplants using donation after brain death and donation after circulatory death organs. Multiorgan transplants and retransplants were not included. Standard surgical techniques were used for the transplant procedures, which remained consistent throughout the study period. During the first 90 days after LT, all recipients were treated under the center's immunosuppression protocol with corticosteroids and tacrolimus as the first-line immunosuppression with a goal plasma level of 6-10 ng/mL. Recipients • Patients who lived >2 hours away discharged home.
• Surgeon or physician assistant visits weekly during the first 3 weeks in addition to hepatologist visits.
• Urgent same-day work-ins with a physician assistant and medical doctor available.
• Infectious disease embedded in the transplant clinic; advanced endoscopy clinic moved to the same building.
• Used the infusion center for IV antibiotics, IV steroids, and blood products.
• Patients who lived >2 hours away discharged to hospitality house (hospital hotel) up to 2 weeks.
Enhance discharge planning and teaching
• After transplant, teaching medications and transplant care started the day before or day of discharge.
• Written instructions of medication without images of pills provided.
• Recipients who could have been discharged on the weekend waited until Monday for discharge teaching.
• Initiate discharge teaching the day after patient is discharged from ICU to floor.
• Pharmacist provides visual aids/images of medications and reviews side effects and dosage.
• Improved discharge planning. If anticipated, a recipient may be discharged on the weekend because the recipient was taught by the coordinator and pharmacist on Friday.
Admitting under observation status • Low threshold to readmit regardless of chief complaint.
• No coordination of procedures or consults prior to readmission.
• Appropriately admit patients under observation status if indicated. Improved coordination of care with consultants by earlier notification of patient return.
Examples of changes that occurred after protocol implementation
Recipient calls coordinator with fever Refer to emergency room and admitted or transferred and admitted. transplanted for primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), autoimmune hepatitis, or fulminant hepatic failure also received mycophenolate mofetil. The same 3 transplant surgeons operated over the study period. LT recipients were admitted on the day of transplant to the transplant surgery service and the first 90 days after transplant for any readmission. The first full year of protocol implementation was 2014. Consequently, readmission rates within 90 days of LT for January 2014 to March 2017 (after protocol implementation) were compared with 2012 and 2013 (before protocol implementation). Multiple readmissions of a single patient were counted as 1 admission, meaning only the first readmission was counted. Pretransplant Model for End-Stage Liver Disease (MELD) score, pretransplant hemodialysis, prior abdominal surgery, diabetes, education level, hepatitis C, prior hospitalization, donor risk index, cold ischemia time, and return to the operating room have previously been shown to be associated with readmission and are included in univariate analyses. (10) (11) (12) (13) (14) (15) (16) (17) The study was approved by the institutional review board.
Categorical variables were compared with Fisher's exact test. Continuous variables were compared with Student t test or Wilcoxon rank sum test where appropriate. Variables identified in the univariate model with a P < 0.1 were included in the multivariable model. Multivariable logistic regression was used to control for potential confounding factors.
Results

stUdY pOpUlatiOn
From January 2012 through March 2017, 304 adult primary liver-only transplants were performed at our center. Characteristics of the study population are shown in Table 2 . The median biological MELD was 22 (interquartile range [IQR], 11). The most common transplant indications were end-stage liver disease from hepatitis C (30%), nonalcoholic fatty liver disease (NAFLD; 21%), and alcohol-related cirrhosis (16%). There were 63 (21%) patients who underwent transplantation with hepatocellular carcinoma (HCC) MELD exception points. The median intensive care unit (ICU) length of stay and total hospital length of stay in days were 2 (IQR, 2) and 8 (IQR, 6), respectively. There were 33 (11%) patients who required hemodialysis before LT, and 34 (11%) patients who required hemodialysis in the early postoperative period. The number of patients hospitalized prior to and up to transplant was 73 (24%).
Over the study period, there were 112 (37%) inpatient readmissions within 90 days after LT. The most common reasons for readmission included elevated liver tests/rejection (n = 26), fever (n = 24), acute kidney injury (AKI)/shortness of breath (n = 16), and gastrointestinal (GI) symptoms (n = 13). Mean and median time from discharge to readmission was 21 ± 20 days and 15 days, respectively. The mean and median length of stay for readmission were 7 ± 11 days and 3 (IQR, 3) days, respectively.
readMissiOn rates BeFOre and aFter iMpleMentatiOn OF tHe prOtOcOl
The 90-day readmission rates before and after implementation of protocol were 53% and 26%, respectively (P < 0.001). The median lengths of stay for the index admission after LT before and after protocol implementation were 8 (IQR, 10) days and 7 (IQR, 4) days, respectively ( Table 2 ). The median time (IQR) from discharge to readmission before and after implementing the protocol were 18 (25) days and 14 (23) days, respectively. The median (IQR) lengths of stay for readmission before and after protocol implementation were 2 (4) and 1 (2) days. The 30-day readmission rates before and after protocol implementation were 40% and 16%, respectively (P < 0.001). The 1-year readmission rates before and after protocol implementation were 68% and 39%, respectively (P < 0.001).
Biliary complication was the most common reason for readmission before the protocol was implemented (accounting for 25% of readmissions), whereas elevated liver tests/rejection was the most common reason after implementing the protocol (accounting for 27% of readmissions). After the protocol was implemented, biliary complications accounted for 4% of readmissions (Table 3) .
In the univariate analysis, age, pretransplant MELD score, prior abdominal surgery, portal vein thrombosis, packed red cell transfusion during transplant, cold ischemia time, operative time, distance lived from transplant center, education level, donor risk index, hospitalization days prior to transplant, pretransplant dialysis, posttransplant dialysis, and diabetes were not associated with readmission (P > 0.1 for all). In the univariate analysis, protocol (P < 0.001), return to the Original article | 1565 
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operating room (P = 0.04), and discharge day (weekend day; P = 0.02) were associated with readmission and included in the multivariable analysis ( Characteristics of recipients who were and were not readmitted within 90 days are shown in Table 5 . Recipients who were readmitted were more likely to have returned to the operating room (P = 0.05) and less likely to have been discharged on a weekend (P = 0.001). We further explored this finding and compared patients who were discharged on a weekend with those discharged on a weekday (Table 6 ). Patients discharged on the weekend were less likely to have diabetes (P = 0.08), to be returned to the operating room (P = 0.07), and to be readmitted for fever.
We evaluated the individual components of the changes we implemented in the protocol that we could quantify to determine the relative impact on reducing readmission. A greater proportion of recipients were discharged to hospital lodging (hospitality house) after protocol than before protocol implementation, 35 (19%) recipients and 12 (10%) recipients, respectively (P = 0.03). The proportion of recipients who were readmitted for ERCP was lower after protocol NOTE: Data are given as n (%). (2) 4 (4) BMI, kg/m 2 , median (IQR) 28 (7) 28 (7) MELD, median (IQR) 21 (11) Original article | 1567 implementation (25% versus 4% before protocol implementation; P < 0.001).
Because the definition of observation status changed over the study period from 24 hours (2012-2013 definition) to a 2-midnight stay (2014-2017 definition), we applied the 2-midnight stay rule in 2012 and 2013 to determine the impact of the change in definition for inpatient readmission. If the same 2-midnight rule was applied over the entire study period, the 90-day inpatient readmission rates before and after protocol implementation were 38% and 26%, respectively (P = 0.03), suggesting that using observation status accounted for 46% of the reduction in the inpatient readmission rate.
cOsts
Inpatients and outpatient costs are shown in Table 7 . Compared with preprotocol costs, postprotocol readmission costs during the first 90 days after LT were reduced by more than 50%: $15,437 and $6974 (P < 0.001). Mean total costs were similar because the 55% reduction in readmission costs after protocol was partly offset by higher outpatient costs and index admission costs.
Over the study period, 90-day and 1-year patient survival rates were 99% and 92%, respectively. The 90-day and 1-year patient survival rates were 98% and 91% before protocol implementation and 99% and 93% after protocol implementation, respectively (P = not significant).
Discussion
The results of the current study demonstrate that improving outpatient access to care after LT is associated with lower inpatient readmission rates and costs during the first 90 days after transplant. Similar to our prior study, (7) the improvement in resource utilization was not at the expense of quality because 90-day and 1-year patient survival rates were similar before and after implementing the protocol. As clinicians and hospitals assume more responsibility for health care costs and utilization, interventions that reduce inpatient readmissions will become increasingly important in delivering high-quality affordable care.
The improvement in the readmission rate was not at the expense of increasing length of stay either for the initial admission at time of transplant or for the NOTE: Data are give as n (%) unless otherwise noted. 1568 | Original article readmission. In fact, the median length of stay for the index admission was shorter by a day after implementing the protocol. Our study demonstrated that the changes we made were sustained because the 30-day readmission rate remained low at 16%, which is numerically better than 20% reported in our prior study. (7) In addition, we did not shift readmissions to beyond 30 days because fewer patients were readmitted from 31-90 days after implementation of the protocol. The reduction in readmission did not come at the expense of quality because 1-year survival was almost identical between the time periods. In fact, readmissions have been associated with worse longterm outcomes, and readmission is likely a marker of a recipient with complications that may negatively impact survival. (18) Prior studies have reported risk factors or predictors for readmission, but none have implemented strategies to reduce 90-day readmission rates. (13) (14) (15) (16) (17) We collected data on factors previously associated with readmission, including dialysis, prior abdominal surgery, diabetes, among others, and most of these variables were not associated with readmission. Weekend discharge was associated with fewer readmissions as we found in our prior study. (7) In the current study, weekend discharges were less likely to have returned to the operating room after LT and have diabetes, so postoperative complications and comorbidities may partly explain higher weekday readmissions in our study. In addition, the discharging physician may have been unwilling to discharge recipients with postoperative complications on weekends and preferentially discharged these patients on weekdays. Also, we speculate that the support team for the recipient may be available to help during the weekends and not during the week.
One key strategy included during protocol development and then subsequently implemented was to increase availability of the hospitality house for recipients who lived 2 or more hours away from the transplant center. The hospitality house is a hospital-owned lodging within walking distance of the transplant center. Recipients housed in the hospitality house could be seen twice a week at the transplant center after discharge or the same day if there was an unforeseen symptom or concern. We found that there was significantly greater utilization of the hospitality house after the protocol was implemented. Prior to implementing greater access to the hospitality house, recipients who lived 2 or more hours away who called with a fever presented to their local emergency room and were subsequently transferred to our hospital. We speculate that many of these outside emergency room to hospital transfers were avoided by housing patients at the hospitality house. In addition, improved coordination of care and timely ERCPs resulted in an 84% reduction in inpatient readmissions for ERCP to evaluate biliary complications.
Despite lowering the readmission rate after implementing the protocol, among recipients readmitted within 90 days of LT, three-quarters of readmissions occurred within the first 30 days, which was similar to when most preprotocol readmissions occurred. A study of 598 LT recipients reported similar findings with the majority of 90-day readmissions occurring within 30 days of transplant. (6) Furthermore, this finding is consistent with other medical conditions, such as heart failure or chronic obstructive pulmonary disease, where 80% of readmissions occur during the first 90 days and the majority of patients with these conditions are readmitted within 30 days after discharge. (19) Thus, to have the greatest impact on reducing readmissions, allocation of resources should focus on the first 30 days after LT, such as improving access to outpatient clinics.
Readmission after LT is associated with significant costs. A study of 11,937 adult LTs included in the University Health System Consortium and Scientific Registry of Transplant Recipients databases reported that a readmission within 90 days of LT accounted for $43,785 of additional cost per patient. (4) In our prior study, we did not include costs. However, we did include them in the current study and found that inpatient readmission costs were significantly reduced by 55%. However, this savings was partly offset by higher outpatient costs and index admission costs.
Limitations to our study included the inability to quantify the impact of the specific strategies we developed in the protocol on the readmission rate. For example, we increased access to same-day outpatient clinic but did not prospectively collect information if the recipient would have been referred to the emergency room. In addition, we did not determine if readmissions were preventable nor include functional status, which has been associated with readmission. (6) Also, only total costs were available, and we were unable to determine the specific components of inpatient and outpatient costs (ie, pharmacy or facility charges) that changed after implementing the protocol. Nevertheless, we provide practical solutions to preventing readmissions that can be incorporated by other centers as well as data on costs that were not included in our prior study.
